University of Basel, Switzerland
Journal of Nanobiotechnology is an open access, peer-reviewed, online journal communicating scientific and technological advances in the fields of medicine and biology, with an emphasis in their interface with nanoscale sciences. The journal provides biomedical scientists and the international biotechnology business community with the latest developments in the growing field of Nanobiotechnology.
The journal will receive its first official Impact Factor in 2014.
Ueli Aebi is Professor and Director of the M.E. Müller Institute for Structural Biology at the Biozentrum, University of Basel, Switzerland. A pioneer of nanobiology and nanomedicine, Ueli earned his Ph.D. in biophysics in 1977 from the University of Basel and continued his research at the University of California in Los Angeles, before joining the faculty at the Johns Hopkins University School of Medicine in Baltimore. After his return to Basel in 1986, Ueli retained strong links with his colleagues in the United States and in 2005 co-founded the American Academy of Nanomedicine (now American Society for Nanomedicine). Ueli has also made longstanding contributions to biotechnology and medtech start-up companies, for example, Alpha-O Peptides that develops drug targeting/delivery and vaccine platforms based upon polyhedral peptide nanoparticles. Ueli’s lab specializes in a structure-based functional understanding of biological nanomachines, and more generally, supramolecular assemblies by a hybrid methods experimental approach that involves light, electron and scanning probe microscopies, X-ray crystallography, molecular cell biology and protein design.